BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9011073)

  • 1. Schistosoma japonicum: immunolocalization of paramyosin during development.
    Gobert GN; Stenzel DJ; Jones MK; Allen DE; McManus DP
    Parasitology; 1997 Jan; 114 ( Pt 1)():45-52. PubMed ID: 9011073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of the target molecule of a protective IgE antibody in secretory glands of Schistosoma japonicum larvae.
    Nara T; Matsumoto N; Janecharut T; Matsuda H; Yamamoto K; Irimura T; Nakamura K; Aikawa M; Oswald I; Sher A
    Int Immunol; 1994 Jul; 6(7):963-71. PubMed ID: 7947464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum.
    McManus DP; Liu S; Song G; Xu Y; Wong JM
    Int J Parasitol; 1998 Nov; 28(11):1739-42. PubMed ID: 9846611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of schistosome proteins.
    Gobert GN
    Microsc Res Tech; 1998 Aug; 42(3):176-85. PubMed ID: 9764918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica.
    Jiz M; Wu HW; Meng R; Pond-Tor S; Reynolds M; Friedman JF; Olveda R; Acosta L; Kurtis JD
    Infect Immun; 2008 Jul; 76(7):3164-9. PubMed ID: 18426875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phage display peptides with affinity for the tegument of Schistosoma japonicum schistosomula.
    Liu Y; Brindley PJ; Zeng Q; Li Y; Zhou J; Chen Y; Yang S; Zhang Z; Liu B; Cai L; McManus DP
    Mol Biochem Parasitol; 2011 Dec; 180(2):86-98. PubMed ID: 21930161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vaccination of mice with recombinant Schistosoma japonicum proteins induces specific anti-parasite antibodies and damage to adult worms after a challenge infection.
    Yang W; Gobert GN; McManus DP
    Int J Parasitol; 1997 Jul; 27(7):843-53. PubMed ID: 9279589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes.
    Waine GJ; Yang W; Scott JC; McManus DP; Kalinna BH
    Vaccine; 1997 Jun; 15(8):846-8. PubMed ID: 9234530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum.
    Ramirez BL; Kurtis JD; Wiest PM; Arias P; Aligui F; Acosta L; Peters P; Olds GR
    Parasite Immunol; 1996 Jan; 18(1):49-52. PubMed ID: 9223156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vaccine against the Asian schistosome, Schistosoma japonicum: an update on paramyosin as a target of protective immunity.
    Kalinna BH; McManus DP
    Int J Parasitol; 1997 Oct; 27(10):1213-9. PubMed ID: 9394192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of the fatty acid-binding protein Sj-FABPc within adult Schistosoma japonicum.
    Gobert GN; Stenzel DJ; Jones MK; McManus DP
    Parasitology; 1997 Jul; 115 ( Pt 1)():33-9. PubMed ID: 9280893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosoma japonicum: localization of calpain in the penetration glands and secretions of cercariae.
    Kumagai T; Maruyama H; Hato M; Ohmae H; Osada Y; Kanazawa T; Ohta N
    Exp Parasitol; 2005 Jan; 109(1):53-7. PubMed ID: 15639140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and immunolocalization of the 22.6 kDa antigen of Schistosoma japonicum.
    Li Y; Auliff A; Jones MK; Yi X; McManus DP
    Parasite Immunol; 2000 Aug; 22(8):415-24. PubMed ID: 10972848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Expression in Developmental Stages of
    Du X; Jones MK; Nawaratna SSK; Ranasinghe S; Xiong C; Cai P; McManus DP; You H
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on paramyosin in parasitic worms.
    Gobert GN; McManus DP
    Parasitol Int; 2005 Jun; 54(2):101-7. PubMed ID: 15866471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and partial nucleotide sequence of Schistosoma japonicum paramyosin: a potential vaccine candidate against schistosomiasis.
    Yang W; Waine GJ; Sculley DG; Liu X; McManus DP
    Int J Parasitol; 1992 Dec; 22(8):1187-91. PubMed ID: 1487380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TGF-beta-like molecules in the life cycle of Schistosoma japonicum.
    Hirata M; Hirata K; Hara T; Kawabuchi M; Fukuma T
    Parasitol Res; 2005 Apr; 95(6):367-73. PubMed ID: 15711848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal administration of Schistosoma japonicum paramyosin induced robust long-lasting systemic and local antibody as well as delayed-type hypersensitivity responses, but failed to confer protection in a mouse infection model.
    Kohama H; Harakuni T; Kikuchi M; Nara T; Takemura Y; Miyata T; Sato Y; Hirayama K; Arakawa T
    Jpn J Infect Dis; 2010 May; 63(3):166-72. PubMed ID: 20495267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SjHSP70, a recombinant Schistosoma japonicum heat shock protein 70, is immunostimulatory and induces protective immunity against cercarial challenge in mice.
    Duan MM; Xu RM; Yuan CX; Li YY; Liu Q; Cheng GF; Lin JJ; Feng XG
    Parasitol Res; 2015 Sep; 114(9):3415-29. PubMed ID: 26091761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramyosin is a major target of the human IgA response against Schistosoma japonicum.
    Hernandez MG; Hafalla JC; Acosta LP; Aligui FF; Aligui GD; Ramirez BL; Dunne DW; Santiago ML
    Parasite Immunol; 1999 Dec; 21(12):641-7. PubMed ID: 10583866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.